Characteristics of Fecal Microbiota in Pediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.

about

Body Mass Index Differences in the Gut Microbiota Are Gender Specific.Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection

P2860

Q55514824-03B28AD3-22DA-4A46-8365-CC18DD708732 Q59132115-40AD86D7-73ED-4FC3-ADA5-3E56F8270743

P2860

Characteristics of Fecal Microbiota in Pediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.

Item

http://www.wikidata.org/entity/Q46250258

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@en

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@nl

type

Item

label

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@en

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@nl

prefLabel

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@en

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@nl

P1476

Characteristics of Fecal Micro ...... ges During Infliximab Therapy.

@en

P2093

Amine Ghozlane

http://www.w3.org/2001/XMLSchema#string

Dan Li

http://www.w3.org/2001/XMLSchema#string

Guangjun Yu

http://www.w3.org/2001/XMLSchema#string

Hui Hu

http://www.w3.org/2001/XMLSchema#string

Ting Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaolu Li

http://www.w3.org/2001/XMLSchema#string

Xuefeng Gao

http://www.w3.org/2001/XMLSchema#string

Yizhong Wang

http://www.w3.org/2001/XMLSchema#string

Yongmei Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

Genetics and pathogenesis of inflammatory bowel disease

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

P31

scholarly article

P356

10.1093/ECCO-JCC/JJX153

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194468

http://www.w3.org/2001/XMLSchema#string

P921

Aka

Characteristics of Fecal Microbiota in Pediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.

about

P2860

P2860

Characteristics of Fecal Microbiota in Pediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P921